Literature DB >> 8922302

Reliability and validity of serum sex hormone measurements.

L M McShane1, J F Dorgan, S Greenhut, J J Damato.   

Abstract

The laboratory reliability and validity of sex hormone measurements were examined at multiple levels, including lower levels characteristic of children and postmenopausal women. Serum was drawn from four adult male and four adult female healthy volunteers. From each individual's serum pool, a medium- and a low-dilution pool were created. Biochemical analyses for total and non-sex hormone-binding globulin (SHBG)-bound estradiol, estrone, estrone sulfate, progesterone, and SHBG were performed on female samples. Male samples were analyzed for total and non-SHBG-bound testosterone, dihydrotestosterone, androstenedione, and dehydroepiandrosterone sulfate. Two aliquots from each pool were assayed twice in each of two labs. All assays except SHBG in one lab used RIA procedures. Reliability was assessed by variance components analyses and estimated coefficients of variation (CVs). Validity was assessed by comparing observed measurements versus expected values based on known dilution ratios. For the testosterone and dihydrotestosterone assays, CVs were usually less than 10%. For estradiol and progesterone, CVs were usually less than 15%. Assays with larger estimated CVs included androstenedione, dehydroepiandrosterone sulfate, estrone, and estrone sulfate. Absolute levels differed markedly between labs for most assays. Observed measurements generally agreed with values expected from the dilution ratios. A notable exception was the estrone assay at the lowest dilution level, where observed measurements were 2-4 times those expected. A similar but less pronounced overestimation bias for the low levels of estradiol was also suggested. This intra- and interlaboratory variability and apparent low dilution overestimation should be accounted for in studies relating hormones to cancer risk, especially those involving children and postmenopausal women.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922302

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  11 in total

Review 1.  Analysis of estrogens and androgens in postmenopausal serum and plasma by liquid chromatography-mass spectrometry.

Authors:  Qingqing Wang; Lisa Bottalico; Clementina Mesaros; Ian A Blair
Journal:  Steroids       Date:  2014-08-20       Impact factor: 2.668

2.  An association between a common variant (G972R) in the IRS-1 gene and sex hormone levels in post-menopausal breast cancer survivors.

Authors:  Jing Fan; Roberta McKean-Cowdin; Leslie Bernstein; Frank Z Stanczyk; Arthur Xuejun Li; Rachel Ballard-Barbash; Anne McTiernan; Richard Baumgartner; Frank Gilliland
Journal:  Breast Cancer Res Treat       Date:  2006-06-05       Impact factor: 4.872

3.  Liquid chromatography/mass spectrometry of pre-ionized Girard P derivatives for quantifying estrone and its metabolites in serum from postmenopausal women.

Authors:  Kannan Rangiah; Sumit J Shah; Anil Vachani; Eugene Ciccimaro; Ian A Blair
Journal:  Rapid Commun Mass Spectrom       Date:  2011-05-15       Impact factor: 2.419

4.  Associations between the CYP17, CYPIB1, COMT and SHBG polymorphisms and serum sex hormones in post-menopausal breast cancer survivors.

Authors:  Page E Abrahamson; Shelley S Tworoger; Erin J Aiello; Leslie Bernstein; Cornelia M Ulrich; Frank D Gilliland; Frank Z Stanczyk; Richard Baumgartner; Kathy Baumgartner; Bess Sorensen; Rachel Ballard-Barbash; Anne McTiernan
Journal:  Breast Cancer Res Treat       Date:  2006-11-01       Impact factor: 4.872

5.  Relation of Serum Estrogen Metabolites with Terminal Duct Lobular Unit Involution Among Women Undergoing Diagnostic Image-Guided Breast Biopsy.

Authors:  Hannah Oh; Zeina G Khodr; Mark E Sherman; Maya Palakal; Ruth M Pfeiffer; Laura Linville; Berta M Geller; Pamela M Vacek; Donald L Weaver; Rachael E Chicoine; Roni T Falk; Hisani N Horne; Daphne Papathomas; Deesha A Patel; Jackie Xiang; Xia Xu; Timothy Veenstra; Stephen M Hewitt; John A Shepherd; Louise A Brinton; Jonine D Figueroa; Gretchen L Gierach
Journal:  Horm Cancer       Date:  2016-05-02       Impact factor: 3.869

6.  Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011.

Authors:  J Bradley Layton; Dongmei Li; Christoph R Meier; Julie L Sharpless; Til Stürmer; Susan S Jick; M Alan Brookhart
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

Review 7.  Analysis of estrogens in serum and plasma from postmenopausal women: past present, and future.

Authors:  Ian A Blair
Journal:  Steroids       Date:  2010-01-28       Impact factor: 2.668

8.  Inter-laboratory validation of the measurement of follicle stimulating hormone (FSH) after various lengths of frozen storage.

Authors:  Jessica Scriver; Valerie L Baker; Steven L Young; Barry Behr; Lisa M Pastore
Journal:  Reprod Biol Endocrinol       Date:  2010-11-29       Impact factor: 5.211

9.  An occupational reproductive research agenda for the third millennium.

Authors:  Christina C Lawson; Teresa M Schnorr; George P Daston; Barbara Grajewski; Michele Marcus; Melissa McDiarmid; Eisuke Murono; Sally D Perreault; Steven M Schrader; Michael Shelby
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

10.  The challenge of measuring circulating estradiol at low concentrations.

Authors:  Paolo Toniolo; Annekatrin Lukanova
Journal:  Breast Cancer Res       Date:  2005-01-12       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.